InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Morningside Venture Investments Ltd. Officer active across 3 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 8 filings have been logged. Total volume traded: €17.7m. The latest transaction was disclosed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
12,857,931 shares
Common Stock
SEC:0000899243-22-011429:0·
10,415,650 shares
Common Stock
SEC:0000899243-22-011432:0·
12,858,188 shares
Common Stock
SEC:0000899243-22-004855·
12,858,188 shares
Common Stock
SEC:0000899243-22-004855:0·
10,415,650 shares
Common Stock
SEC:0000899243-22-003157:0·
10,415,650 shares
Common Stock
SEC:0000899243-22-003157·
€9m250,000 shares@ €35.3320.17% mcap100.0% of flow
Common Stock
SEC:0000899243-21-045265·
Ideal exit: 15 Aug 2022 (T+270)
€9m250,000 shares@ €35.3320.17% mcap50.0% of flow
Common Stock
SEC:0000899243-21-045265:0·
Ideal exit: 15 Aug 2022 (T+270)
8 of 8 declarations
About Morningside Venture Investments Ltd
Morningside Venture Investments Ltd is a director and insider at Apellis Pharmaceuticals, Inc., Amylyx Pharmaceuticals, Inc., and GreenLight Biosciences Holdings, PBC.
